Mark A. Evashenk
Vice President, Clinical Operations
Mr. Evashenk has served as vice president, clinical operations since 2009 and has more than 30 years of pharmaceutical and device development experience with a focus on project management and clinical operations.
Prior to joining AcelRx, Mr. Evashenk was director of clinical operations at ALZA Corporation, a Johnson & Johnson company. Throughout his career he managed two NDA filings and helped lead a clinical operations team for three additional NDA submissions.
Mr. Evashenk has managed clinical operations teams for well over 100 Phase 1 studies, including over 10 first-in-man, and numerous Phase 2, 3 and 3B studies. Mark has managed studies in the US, Canada, Western Europe and Eastern Europe, India and Australia. Mark holds a Bachelor of Science in environmental toxicology from the University of California at Davis.